Skip to main content

Table 2 Medication/treatment variables including treatment experiences (n = 411)

From: Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria

  Characteristics

Frequency

Percentage

  Duration of treatment (months)

  

  <12

120

29.2

  12-24

108

26.3

  >24

183

44.5

  Median duration of treatment (range)

24 (3–192)

 

  Encountered side effects

  

  Yes

226

55.0

  No

185

45.0

  Herbal use

  

  Yes

138

33.6

  No

273

66.4

  Number of pills/ day

  

  ≤2

282

68.6

  3-4

112

27.3

  >4

17

4.1

  Presence of opportunistic infection

  

  Yes

32

7.8

  No

379

92.2

  Paid for ART services

  

  Yes

49

11.9

  No

362

88.1

  Perceived health status as improved   since commencement of HAART

  

  Improved

386

93.9

  No improvement

25

6.1

  Perceived health rating

  

  Excellent

39

9.5

  Very good

253

61.6

  Good

92

22.4

  Fair/poor

27

6.6

  Transportation cost to Health facility

  

  <N1000

275

66.9

  ≥N1000

136

33.1